Works matching IS 00071188 AND DT 2024 AND VI 181 AND IP 14

Results: 19

The small‐molecule formyl peptide receptor biased agonist, compound 17b, is a vasodilator and anti‐inflammatory in mouse precision‐cut lung slices.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2287, doi. 10.1111/bph.16231

By:

Studley, William R.;
Lamanna, Emma;
Martin, Katherine A.;
Nold‐Petry, Claudia A.;
Royce, Simon G.;
Woodman, Owen L.;
Ritchie, Rebecca H.;
Qin, Cheng Xue;
Bourke, Jane E.

Publication type:

Article

Cannabinoid CB2 receptor orthologues; in vitro function and perspectives for preclinical to clinical translation.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2247, doi. 10.1111/bph.16172

By:

Carruthers, Emma R.;
Grimsey, Natasha L.

Publication type:

Article

Highlights and hot topics in GPCR research from 'Down Under'.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2091, doi. 10.1111/bph.16419

By:

Smith, Nicola J.;
May, Lauren T.;
Grimsey, Natasha L.

Publication type:

Article

Molecular insights into orphan G protein‐coupled receptors relevant to schizophrenia.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2095, doi. 10.1111/bph.16221

By:

Lu, Yao;
Hatzipantelis, Cassandra J.;
Langmead, Christopher J.;
Stewart, Gregory D.

Publication type:

Article

The application of artificial intelligence to accelerate G protein‐coupled receptor drug discovery.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2371, doi. 10.1111/bph.16140

By:

Nguyen, Anh T. N.;
Nguyen, Diep T. N.;
Koh, Huan Yee;
Toskov, Jason;
MacLean, William;
Xu, Andrew;
Zhang, Daokun;
Webb, Geoffrey I.;
May, Lauren T.;
Halls, Michelle L.

Publication type:

Article

Issue Information.

Published in:: British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2089, doi. 10.1111/bph.16129
Publication type:: Article

Targeting G protein‐coupled receptors for heart failure treatment.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2270, doi. 10.1111/bph.16099

By:

Thai, Bui San;
Chia, Ling Yeong;
Nguyen, Anh T. N.;
Qin, Chengxue;
Ritchie, Rebecca H.;
Hutchinson, Dana S.;
Kompa, Andrew;
White, Paul J.;
May, Lauren T.

Publication type:

Article

RAMP and MRAP accessory proteins have selective effects on expression and signalling of the CB1, CB2, GPR18 and GPR55 cannabinoid receptors.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2212, doi. 10.1111/bph.16095

By:

Glenn, Nathaniel A. K.;
Finlay, David B.;
Carruthers, Emma R.;
Mountjoy, Kathleen G.;
Walker, Christopher S.;
Grimsey, Natasha L.

Publication type:

Article

The role of the adenosine system in epilepsy and its comorbidities.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2143, doi. 10.1111/bph.16094

By:

Baltos, Jo‐Anne;
Casillas‐Espinosa, Pablo M.;
Rollo, Ben;
Gregory, Karen J.;
White, Paul J.;
Christopoulos, Arthur;
Kwan, Patrick;
O'Brien, Terence J.;
May, Lauren T.

Publication type:

Article

The application of targeted protein degradation technologies to G protein‐coupled receptors.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2351, doi. 10.1111/bph.16079

By:

Keen, Alastair C.;
Jörg, Manuela;
Halls, Michelle L.

Publication type:

Article

The roles of RGS proteins in cardiometabolic disease.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2319, doi. 10.1111/bph.16076

By:

McNeill, Samantha M.;
Zhao, Peishen

Publication type:

Article

Mas‐related G protein‐coupled receptors in gastrointestinal dysfunction and inflammatory bowel disease: A review.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2197, doi. 10.1111/bph.16059

By:

Hawker, Patrick;
Zhang, Li;
Liu, Lu

Publication type:

Article

Single nucleotide variations encoding missense mutations in G protein‐coupled receptors may contribute to autism.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2158, doi. 10.1111/bph.16057

By:

van der Westhuizen, Emma T.

Publication type:

Article

Primary cilia, A‐kinase anchoring proteins and constitutive activity at the orphan G protein‐coupled receptor GPR161: A tale about a tail.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2182, doi. 10.1111/bph.16053

By:

Patel, Kinjal;
Smith, Nicola J.

Publication type:

Article

Unravelling G protein‐coupled receptor signalling networks using global phosphoproteomics.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2359, doi. 10.1111/bph.16052

By:

Pokhrel, Rina;
Morgan, Alexandra L.;
Robinson, Harley R.;
Stone, Martin J.;
Foster, Simon R.

Publication type:

Article

Therapeutic potential of allosteric modulators for the treatment of gastrointestinal motility disorders.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2232, doi. 10.1111/bph.16023

By:

Saito, Ayame;
Alvi, Sadia;
Valant, Celine;
Christopoulos, Arthur;
Carbone, Simona E.;
Poole, Daniel P.

Publication type:

Article

Importance of receptor expression in the classification of novel ligands at the M2 muscarinic acetylcholine receptor.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2338, doi. 10.1111/bph.16021

By:

Jiang, Ye;
Yeasmin, Mahmuda;
Gondin, Arisbel B.;
Christopoulos, Arthur;
Valant, Celine;
Burger, Wessel A. C.;
Thal, David M.

Publication type:

Article

Functional crosstalk between angiotensin receptors (types 1 and 2) and relaxin family peptide receptor 1 (RXFP1): Implications for the therapeutic targeting of fibrosis.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2302, doi. 10.1111/bph.16019

By:

Samuel, Chrishan S.;
Li, Yifang;
Wang, Yan;
Widdop, Robert E.

Publication type:

Article

Opportunities and challenges for the development of M1 muscarinic receptor positive allosteric modulators in the treatment for neurocognitive deficits.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2114, doi. 10.1111/bph.15982

By:

Nguyen, Huong T. M.;
van der Westhuizen, Emma T.;
Langmead, Christopher J.;
Tobin, Andrew B.;
Sexton, Patrick M.;
Christopoulos, Arthur;
Valant, Celine

Publication type:

Article

Works matching IS 00071188 AND DT 2024 AND VI 181 AND IP 14

The small‐molecule formyl peptide receptor biased agonist, compound 17b, is a vasodilator and anti‐inflammatory in mouse precision‐cut lung slices.

Cannabinoid CB<sub>2</sub> receptor orthologues; in vitro function and perspectives for preclinical to clinical translation.

Highlights and hot topics in GPCR research from 'Down Under'.

Molecular insights into orphan G protein‐coupled receptors relevant to schizophrenia.

The application of artificial intelligence to accelerate G protein‐coupled receptor drug discovery.

Issue Information.

Targeting G protein‐coupled receptors for heart failure treatment.

RAMP and MRAP accessory proteins have selective effects on expression and signalling of the CB<sub>1</sub>, CB<sub>2</sub>, GPR18 and GPR55 cannabinoid receptors.

The role of the adenosine system in epilepsy and its comorbidities.

The application of targeted protein degradation technologies to G protein‐coupled receptors.

The roles of RGS proteins in cardiometabolic disease.

Mas‐related G protein‐coupled receptors in gastrointestinal dysfunction and inflammatory bowel disease: A review.

Single nucleotide variations encoding missense mutations in G protein‐coupled receptors may contribute to autism.

Primary cilia, A‐kinase anchoring proteins and constitutive activity at the orphan G protein‐coupled receptor GPR161: A tale about a tail.

Unravelling G protein‐coupled receptor signalling networks using global phosphoproteomics.

Therapeutic potential of allosteric modulators for the treatment of gastrointestinal motility disorders.

Importance of receptor expression in the classification of novel ligands at the M<sub>2</sub> muscarinic acetylcholine receptor.

Functional crosstalk between angiotensin receptors (types 1 and 2) and relaxin family peptide receptor 1 (RXFP1): Implications for the therapeutic targeting of fibrosis.

Opportunities and challenges for the development of M<sub>1</sub> muscarinic receptor positive allosteric modulators in the treatment for neurocognitive deficits.